With the rise in prescription drug prices in recent years, many Americans have been forced to choose between paying for medication and other necessities like rent or groceries. The passage of the Inflation Reduction Act in 2022 changed that for those on Medicare, providing some relief by capping costs for beneficiaries.
That progress is now in jeopardy with a new Trump administration that has voiced support for repeal of the Inflation Reduction Act’s protections. Doing so could also squash any hope for extending prescription drug price protections for a much larger portion of Americans: the privately insured.
I wrote about that for Public Health Post. Read the full piece here.
Research for this article was supported by Arnold Ventures.
